Evolent Health Inc Cl A Com (EVH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 1,876,229 | 2,554,741 | 1,963,896 | 1,352,013 | 907,957 |
| Cost of Goods | 1,476,346 | 2,187,388 | 1,503,426 | 1,035,429 | 657,551 |
| Gross Profit | 399,883 | 367,353 | 460,470 | 316,584 | 250,406 |
| Operating Expenses | 810,367 | 408,226 | 532,107 | 313,371 | 293,368 |
| Operating Income | -410,138 | -40,485 | -71,211 | 3,642 | -42,411 |
| Interest Expense | 57,471 | 24,722 | 54,205 | 15,572 | 25,425 |
| Other Income | -67,027 | 2,171 | -76,989 | -50,147 | 38,035 |
| Pre-tax Income | -534,636 | -63,036 | -202,405 | -62,077 | -29,801 |
| Income Tax | -126 | -1,413 | -89,365 | -43,376 | 483 |
| Net Income Continuous | -534,510 | -61,623 | -113,040 | -18,701 | -30,284 |
| Net Income Discontinuous | N/A | N/A | N/A | -463 | -7,317 |
| Net Income | $-534,510 | $-61,623 | $-113,040 | $-19,164 | $-37,601 |
| EPS Basic Total Ops | -5.07 | -0.81 | -1.28 | -0.20 | -0.44 |
| EPS Basic Continuous Ops | -4.68 | -0.54 | -1.02 | -0.20 | -0.35 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.00 | -0.09 |
| EPS Diluted Total Ops | -5.07 | -0.81 | -1.28 | -0.20 | -0.44 |
| EPS Diluted Continuous Ops | -4.68 | -0.54 | -1.02 | -0.20 | -0.35 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.00 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -0.18 | 0.14 | 0.42 | 0.59 | -0.18 |
| EBITDA(a) | $118,311 | $86,230 | $66,960 | $96,195 | $48,712 |